Data Monitoring Experience in the AIDS Toxoplasmic Encephalitis Study
The toxoplasmic encephalitis (TOXO) study was designed to determine whether primary prophylaxis with pyrimethamine (25 mg thrice weekly) or clinidamycin (300 mg twice daily) would reduce the incidence of toxoplasmic encephalitis (TE) among HIV-infected patients considered at risk for the opportunistic infection. Using a modified double-blind design, patients were randomized to clindamycin or matching placbo (2 : 1) or to pyrimethamine or matching placebo (2 : 1). The clindamycin arm of the study was terminated after a median follow-up of three months due to dose-limiting toxcities; the pyrimethamine arm was terminated after a median follow-up of eight months due to a very low TE event rate in the placebo and pyrimethamine groups and a higher death rate among patients assigned pyrimethamine.
KeywordsInterim Analysis Pneumocystis Carinii Pneumonia Primary Prophylaxis Case Study Approach Toxoplasmic Encephalitis
Unable to display preview. Download preview PDF.
- 2.Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J. 1999. Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. Morbidity & Mortality Weekly Report. CDC Surveillance Summaries 48(2):1–22.Google Scholar
- 4.Luft BJ, Remington JS: Toxoplasmosis of the central nervous system. 1985. In Remington JS, Swartz MN (eds.): Current Clinical Topics in Infectious Disease Vol 6., pp. 315–358, McGraw Hill, New York.Google Scholar
- 9.Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, et al. 1992. A controlled trial of trimethoprim-sulfamethoxazole ir aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in pateints with the acquired immunodeficiency syndrome. N Engl J Med 27:1842–1848.CrossRefGoogle Scholar
- 10.Guidance for clinical trial sponsors on the establishment and operation of clinical trial data monitoring committees. www.fda.gov/cber/gdlns/clindatmon.htmGoogle Scholar
- 11.Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA. 1992. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 117:106–111.Google Scholar
- 13.Masur H, Kaplan JE, Holmes KK. 2002. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 137:435–478.Google Scholar